Robert Bider, a Swiss national, holds a PhD in Sciences and a Master in Industrial Management (MIM) from the Federal Institute of Technology, Zurich (ETHZ). Mr. Bider started his career in 1972 as Head of the Organization Department of the University Hospital, Zurich. In 1977, he became Head of the Consulting Department of the Swiss Hospital Institute. From 1985 to 2008, he was Chief Executive Officer of Hirslanden, where he devised and executed the expansion scheme of Hirslanden from a single hospital to the largest Swiss private hospital group with 1300 beds, over 100 centres of competence, 5'000 employees and a turnover of CHF 1.1 billion. He is Chairman of the Hirslanden Research Foundation, the Robert Bider Foundation, member of the Foundation for the Lucerne Symphony Orchestra and President of the Swiss Corporate Tennis Association. Mr. Bider is also Chairman of European Medical Network EMN AG and member of the non-executive Board of Median Kliniken. Further, he is on the board of Pioneer Medical Devices AG, Lumendi Ltd., Embru AG and Montana Capital Partners AG. He was Chairman of the Board of SENIOcare AG, the largest Swiss chain of nursing homes, from 2009 until it was sold to Swiss Prime Site in 2015. He was also a board member of Grand Resort Bad Ragaz, Medi-Clinic Switzerland AG, Medi-Clinic Corporation Ltd. and Rhino-Partners AG.
Patrick Schildknecht, a Swiss national, holds a master of business administration at the University of Zurich. He started his career with the door manufacturer Portico S.A. in San Jose, Costa Rica. After returning to Switzerland in 1999, he worked five years as a strategy consultant with Arthur D. Little in Singapore and Switzerland. In 2004 he served as owner and CEO of Sycrilor Industries S.A. in Le Noirmont, a precision forge for the luxury goods and medical industry. Mr. Schildknecht is the owner and president of SK Holding AG in Euthal, an investment company with several subsidiaries in retail trading as well as in the property development and building materials sectors. Patrick Schildknecht has acted as a member of the Board of Directors in several public and private companies.
Thomas Rühle, a German national, holds a degree in economics from the BA Karlsruhe. He served as Vice President Europe of Sanofi Pasteur MSD from 2005 till 2011. Previously, he acted as Chairman for the region Germany at Sanofi Pasteur MSD. Prior to Sanofi Pasteur MSD he held several marketing positions at leading pharmaceutical companies. Today he is involved in several healthcare and logistics companies as a private investor.
Raymond W. Cohen, a citizen of the United States of America, is an accredited public company director and medical device veteran with over 30 years of operating and board level experience. Mr. Cohen currently serves as the CEO and a board member of Axonics Modulation Technologies, Inc. Irvine, CA, USA. Mr. Cohen is a member of several boards of Directors; he is Chairman of the Board of Lombard Medical Inc. Didcot, UK, Chairman of the Board of BioLife Solutions Inc., Bothell, WA, a Board member of Spectrum Pharmaceuticals Inc., Henderson, NV, a Board member of JenaValve Technology, Irvine, CA, and Chairman of the Board, Syncroness, Inc., Westminster, CO.
Markus Breitenmoser, Swiss citizen, holds a Master of Business Administration from the University of St. Gallen (HSG), with studies at the ETH Zurich and UC Berkeley. In 1989, Markus started his international career as Project Manager with Ascom; in 1993, he became Vice-President in Investment Banking and M&A at Credit Suisse First Boston; from 1998, he was Partner and Co-owner with the Asset Manager Actienbank; in 2004, he became Partner and Head of Corporate Finance at Arthur D. Little Central Europe; in 2007, he became Director of Helbling Business Advisors.
In 2010, Markus started a firm and a few business projects on his own. He also became a Board Member of Precious Wood Holding until 2012. Markus currently is: Chairman of Novelteak and its subsidiaries in Costa Rica, Nicaragua and Panama, with teak plantations, some 17’000 hectares land owned, and international operations; Chairman of MCBM Beteiligungen; Board Member of Alpora, a research provider to the financial industry and companies in Europe, focused on innovation and business efficiency; and Managing Director of Breitenmoser Management GmbH, a consulting firm that is active worldwide in market positioning and restructuring projects for Swiss and German clients.